@fibronostics

Mitigating risk by detecting undiagnosed disease through non-invasive, algorithm-based diagnostics.

 United States
fibronostics.com
Joined January 2018
  • Tweets367
  • Following2.4K
  • Followers740
158Media
Fibronostics retweeted
AASLD
@AASLDtweets23 Mar 2020
AASLD has created "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic" It provides data on #COVID19, & how it may affect hepatologists & liver transplant providers & their patients. Read it: bit.ly/2wwp9N8 #LiverTwitter #LTx
58
22
73
🌎 #Liver History: "The first acknowledged case of obesity-related non-alcoholic fatty liver was observed in 1952 by Samuel Zelman." — @JAMAInternalMed #NAFLD #NASH
4
14
Fibronostics retweeted
AASLD
@AASLDtweets6 Mar 2020
From @CLD_Learning: "60 Days in Biliary Atresia: A Historical Dogma Challenged" bit.ly/2TGeVRJ #AASLDjournals #BA #LiverTwitter
2
6
Prof Brent Neuschwander-Tetri provides a comprehensive overview of the therapeutic landscape for #NAFLD #NASH in 2020 with a focus on drugs in advanced clinical development→jmp.sh/dOjrPgV @AGA_Gastro @AmerGastroAssn
6
15
Fibronostics retweeted
AASLD
@AASLDtweets14 Feb 2020
JOIN THE CONVERSATION There's a great discussion around Alcohol Free Beer taking place in Engage, AASLD's online community. Have something to contribute to the conversation? Check it out 👉 engage.aasld.org/ #MemberBenefit #AlcoholFreeBeer #ALDsig
1
7
Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in #Taiwan🇹🇼: Experience at a teaching hospital➡️jmp.sh/5IhNpdy @BMC_series #NAFLD #NASH #FattyLiver #非酒精性脂肪肝
1
3
10
#DYK how common #NAFLD and #NASH are? The currently estimated prevalence of these #liver disease is alarming and should not be ignored. Learn more 👉 bit.ly/NASH-Prevalence #NASHedu #FattyLiver #LiverDisease
5
1
3
Fibronostics retweeted
Lark Health@larkhealth13 Jan 2020
ICYMI: We are proud to be named by @FierceHealth as one of the 2020 #Fierce15 companies. As one of the "most promising health care companies in the industry", Lark is "rethinking the way healthcare is delivered".#JPM20 #JPMHC20 #digitalhealth fiercehealthcare.com/special…
1
4
1
11
Fibronostics retweeted
NPR
@NPR9 Jan 2020
Death certificates spanning 2017 indicate nearly 73,000 people died in the U.S from liver disease and other alcohol-related illnesses. That's up from under 36,000 deaths in 1999. trib.al/dyVTI7P
49
120
44
192
Improvements needed for hepatitis C testing in youth. bit.ly/36OxmZl
1
Fibronostics retweeted
AASLD
@AASLDtweets10 Jan 2020
From @HepCommJournal: "Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts ➡️➡️Recovery from Cholestatic Injury" bit.ly/35AZfTS #VisualAbstract #OpenAccess #AASLDjournals @GiTmdu
3
5
⛰️ NASH-TAG begins Tomorrow! Welcome reception is at 6:00 p.m. 😃 We'll see you soon. #MedEd #Education #Healthcare
3
6
Fibronostics retweeted
AASLD
@AASLDtweets7 Jan 2020
December 2019 UPDATE -- AASLD has updated its Hepatitis C Guidance. Get the latest here 👉 bit.ly/2Zd32Ug #PracticeGuidelines #HCV #HepC #HotOffThePress
4
7
Looking forward to seeing you there! #healthy #liver #LIVERFAST – at Parsippany, NJ
Teresa Gonzalo@TeresaGonzalo18 Dec 2019
Proud to be part of #LIVERFASt team to help screen liver damage @NashTagConf looking forward helping people understand the importance of a #healthy #liver
1
1
📰 Check out our announcement in the Salt Lake City Patch! Read more @ @SaltLakePatch: lnkd.in/e5Rbbta #meded #utah #conferences #cme #NASH #research #development #liver – at Salt Lake City, UT
3
1
3
Proud to be part of #LIVERFASt team to help screen liver damage @NashTagConf looking forward helping people understand the importance of a #healthy #liver
Fibronostics@fibronostics12 Dec 2019
Healthcare providers need better tools to assess risk and detect the earliest signs of liver disease. Download our whitepaper, Non-Invasive Assessment of Liver Fibrosis, Inflammation and Steatosis, to learn more: bit.ly/2sdWx91 #liverfast #liverdisease #nafld #nash
1
1
3
Fibronostics retweeted
AASLD
@AASLDtweets17 Dec 2019
The Best of The Liver Meeting® 2019 highlights key presentations from the meeting and provides insights for patient care and ongoing research. To learn more, visit liverlearning.aasld.org/reso… #LiverMtg19
2
5
We will be there with @fibronostics team in January! #ArtificialInteligence #NASH #LIVERFASt #fattyliver
NASH-TAG Conference@NashTagConf13 Dec 2019
📰 Check out our announcement in the Salt Lake City Patch! Read more @ @SaltLakePatch: lnkd.in/e5Rbbta #meded #utah #conferences #cme #NASH #research #development #liver
2
3
Diet-Induced Rat Model of Gradual Development of Non-Alcoholic Fatty Liver Disease (NAFLD) with Lipopolysaccharides (LPS) Secretion. ncbi.nlm.nih.gov/pubmed/3178…
3
1
#DYK up to 70% of individuals with #Type2Diabetes have an associated #NAFLD, and 25-30% have #NASH? This population is at higher-risk of non-alcoholic fatty #LiverDisease 👉 bit.ly/NASH-Riskfactors #NASHedu #FattyLiver #comorbidities #diabetes #T2D
9
6
Load more